South Denver Podiatry Llc - Medicare Podiatrist in Littleton, CO

South Denver Podiatry Llc is a medicare enrolled "Podiatrist" provider in Littleton, Colorado. Their current practice location is 7780 S Broadway Ste 190, Littleton, Colorado. You can reach out to their office (for appointments etc.) via phone at (720) 515-2531.

South Denver Podiatry Llc is licensed to practice in Colorado (license number POD.0000701) and it also participates in the medicare program. South Denver Podiatry Llc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1538677976.

Contact Information

South Denver Podiatry Llc
7780 S Broadway Ste 190,
Littleton, CO 80122-2641
(720) 515-2531
Not Available



Healthcare Provider's Profile

Full NameSouth Denver Podiatry Llc
TypeFacility
SpecialityPodiatrist
Location7780 S Broadway Ste 190, Littleton, Colorado
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1538677976
  • Provider Enumeration Date: 01/19/2018
  • Last Update Date: 01/19/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 3779845169
  • Enrollment ID: O20180323000346

Medical Identifiers

Medical identifiers for South Denver Podiatry Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1538677976NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
213E00000XPodiatrist POD.0000701 (Colorado)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. South Denver Podiatry Llc acts as a billing entity for following providers:
Provider NameKarolina S Varnay
Provider TypePractitioner - Podiatry
Provider IdentifiersNPI Number: 1285807198
PECOS PAC ID: 4981861754
Enrollment ID: I20120816000961

News Archive

World Bank updates on malaria situation in Africa

A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.

Kellogg investigators develop new nanotechnology that has potential to kill tumor cells in the eye

Researchers at the University of Michigan Kellogg Eye Center have developed a new nanoparticle that uses a tumor cell's protective mechanism against itself - short-circuiting tumor cell metabolism and killing tumor cells.

Ebixa (memantine) approved for the treatment of moderate Alzheimer's disease

The Committee for Medicinal Products for Human Use (CHMP) has announced its decision to extend Ebixa's current indication (moderately severe to severe disease) to include moderate stages of Alzheimer's disease (AD).

Phase III clinical study: Vimpat demonstrates fewer partial-onset seizures versus placebo in adults with epilepsy

UCB today announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia.

Read more Medical News

› Verified 3 days ago

Provider NameAdrianne Kornblith
Provider TypePractitioner - Podiatry
Provider IdentifiersNPI Number: 1326576943
PECOS PAC ID: 9335550409
Enrollment ID: I20201120000535

News Archive

World Bank updates on malaria situation in Africa

A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.

Kellogg investigators develop new nanotechnology that has potential to kill tumor cells in the eye

Researchers at the University of Michigan Kellogg Eye Center have developed a new nanoparticle that uses a tumor cell's protective mechanism against itself - short-circuiting tumor cell metabolism and killing tumor cells.

Ebixa (memantine) approved for the treatment of moderate Alzheimer's disease

The Committee for Medicinal Products for Human Use (CHMP) has announced its decision to extend Ebixa's current indication (moderately severe to severe disease) to include moderate stages of Alzheimer's disease (AD).

Phase III clinical study: Vimpat demonstrates fewer partial-onset seizures versus placebo in adults with epilepsy

UCB today announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia.

Read more Medical News

› Verified 3 days ago

Provider NameEmily Marie Opp
Provider TypePractitioner - Podiatry
Provider IdentifiersNPI Number: 1396207296
PECOS PAC ID: 3274911813
Enrollment ID: I20220609001910

News Archive

World Bank updates on malaria situation in Africa

A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.

Kellogg investigators develop new nanotechnology that has potential to kill tumor cells in the eye

Researchers at the University of Michigan Kellogg Eye Center have developed a new nanoparticle that uses a tumor cell's protective mechanism against itself - short-circuiting tumor cell metabolism and killing tumor cells.

Ebixa (memantine) approved for the treatment of moderate Alzheimer's disease

The Committee for Medicinal Products for Human Use (CHMP) has announced its decision to extend Ebixa's current indication (moderately severe to severe disease) to include moderate stages of Alzheimer's disease (AD).

Phase III clinical study: Vimpat demonstrates fewer partial-onset seizures versus placebo in adults with epilepsy

UCB today announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. South Denver Podiatry Llc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
South Denver Podiatry Llc
7780 S Broadway Ste 190,
Littleton, CO 80122-2641

Ph: (720) 515-2531
South Denver Podiatry Llc
7780 S Broadway Ste 190,
Littleton, CO 80122-2641

Ph: (720) 515-2531

News Archive

World Bank updates on malaria situation in Africa

A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.

Kellogg investigators develop new nanotechnology that has potential to kill tumor cells in the eye

Researchers at the University of Michigan Kellogg Eye Center have developed a new nanoparticle that uses a tumor cell's protective mechanism against itself - short-circuiting tumor cell metabolism and killing tumor cells.

Ebixa (memantine) approved for the treatment of moderate Alzheimer's disease

The Committee for Medicinal Products for Human Use (CHMP) has announced its decision to extend Ebixa's current indication (moderately severe to severe disease) to include moderate stages of Alzheimer's disease (AD).

Phase III clinical study: Vimpat demonstrates fewer partial-onset seizures versus placebo in adults with epilepsy

UCB today announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia.

Read more News

› Verified 3 days ago


Podiatrist in Littleton, CO

Dr. Alfred Kwon, DPM
Podiatrist
Medicare: Accepting Medicare Assignments
Practice Location: 10268 W Centennial Rd Ste 104, Littleton, CO 80127
Phone: 303-933-5048    
James Pettet Dpm Pc Inc
Podiatrist
Medicare: Medicare Enrolled
Practice Location: 151 W Mineral Ave Ste 110, Littleton, CO 80120
Phone: 303-730-2955    Fax: 303-798-7037
Dr. James C. Dill, D.P.M.
Podiatrist
Medicare: Not Enrolled in Medicare
Practice Location: 6169 S Balsam Way Ste 320, Littleton, CO 80123
Phone: 303-973-3668    Fax: 303-347-9339
Mrs. Sarah Tanya Benjamin, DPM
Podiatrist
Medicare: Accepting Medicare Assignments
Practice Location: 7780 S Broadway Ste 255, Littleton, CO 80122
Phone: 303-470-1830    
Littleton Foot And Ankle Pllc
Podiatrist
Medicare: Medicare Enrolled
Practice Location: 10268 W Centennial Rd Ste 104, Littleton, CO 80127
Phone: 303-933-5048    Fax: 844-269-7473
Medical And Surgical Foot And Ankle Care, Pc
Podiatrist
Medicare: Medicare Enrolled
Practice Location: 6169 S Balsam Way, 270, Littleton, CO 80123
Phone: 303-932-7957    Fax: 303-933-8271
Emily Marie Opp,
Podiatrist
Medicare: Accepting Medicare Assignments
Practice Location: 7780 S Broadway Ste 190, Littleton, CO 80122
Phone: 720-398-8450    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.